Thiophenacetamide as a potential modulator to NF-κB: structure and dynamics study using in silico and molecular biology assays
- 11 January 2019
- journal article
- research article
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 37 (16) , 4395-4406
Abstract
Nuclear factor kappa B (NF-κB) plays critical roles in the regulation of many pathophysiological processes, including inflammation and immune responses, cell growth and apoptosis. This DNA-binding protein receptor is considered an important molecular target to treat many diseases through host-directed therapy. In this line, several drugs containing thiophene cores have been extensively evaluated due to their ability to interfere on NF-κB translocation to the nucleus. In this work, essays using drug affinity responsive target stability (DARTS) revealed that the parent compound N-(Aryl)-2-thiophen-2-ylacetamide referred to as thiophenacetamide (TAA) specifically binds to the p65 subunit of the NF-κB. Since no experimental binding mode of TAA with p65 is available, we explored TAA within putative sites in silico to gain insights into its possible binding mode and behavior. The binding mode of TAA found in Site 1 formed hydrogen bonds with Lys37 and Asp125 on p65, important residues near DNA-binding region. Molecular dynamics simulations showed the stability of this mode of binding in contrast to the other also tested modes. Our results suggest that TAA binding could occur in regions close to residues responsible for DNA-binding, increasing NF-κB protein rigidity and affecting the association between DNA and NF-κB.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento CientÃfico e Tecnológico (407741/2012-7)
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (E-26/111.401/2013)
This publication has 48 references indexed in Scilit:
- GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkitBioinformatics, 2013
- FTSite: high accuracy detection of ligand binding sites on unbound protein structuresBioinformatics, 2011
- NNScore 2.0: A Neural-Network Receptor–Ligand Scoring FunctionJournal of Chemical Information and Modeling, 2011
- Structural studies of NF-κB signalingCell Research, 2010
- Inhibiting NF-κB activation by small molecules as a therapeutic strategyBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2010
- A machine learning approach to predicting protein–ligand binding affinity with applications to molecular dockingBioinformatics, 2010
- Improved side‐chain torsion potentials for the Amber ff99SB protein force fieldProteins: Structure, Function, and Bioinformatics, 2010
- Target identification using drug affinity responsive target stability (DARTS)Proceedings of the National Academy of Sciences, 2009
- An Atomic Model of the Interferon-β EnhanceosomeCell, 2007
- Inhibitors of NF-κB signaling: 785 and countingOncogene, 2006